Title:
EXERCISE FUNCTION-IMPROVING AGENT
Document Type and Number:
Japanese Patent JP2014141496
Kind Code:
A
Abstract:
PROBLEM TO BE SOLVED: To provide an exercise function-improving agent, an endurance-improving agent, a fatigue-resisting agent, a muscular strength-improving agent, a glycogen reserve-promoting agent and a muscular pumping ability-improving agent which are safe, easily obtained and excellent in processability.SOLUTION: Disclosed is an oral solid preparation or a nutritional support composition which contains 2-50 mass% of a fat globule membrane component, preferably 1-50 mass% of sphingomyelin in terms of dry substance. The function-improving agent is used as exercise function-improving agent, an endurance-improving agent, a fatigue-resisting agent, a muscular strength-improving agent, a glycogen reserve-promoting agent and a muscular pumping ability-improving agent.
Inventors:
OTA NOBUYASU
HARAMIZU SATOSHI
MURASE TAKATOSHI
HARAMIZU SATOSHI
MURASE TAKATOSHI
Application Number:
JP2014040738A
Publication Date:
August 07, 2014
Filing Date:
March 03, 2014
Export Citation:
Assignee:
KAO CORP
International Classes:
A61K31/688; A23K1/16; A23L1/30; A61K35/20; A61P3/02; A61P21/00
Domestic Patent References:
| JP2007246404A | 2007-09-27 | |||
| JP2007112793A | 2007-05-10 |
Foreign References:
| WO2007138749A1 | 2007-12-06 | |||
| WO2008016108A1 | 2008-02-07 |
Attorney, Agent or Firm:
Alga Patent Office, a patent business corporation
Toshio Takano
Toshio Nakajima
Masaki Murata
Hiroto Yamamoto
Toshio Takano
Toshio Nakajima
Masaki Murata
Hiroto Yamamoto
Previous Patent: ANTIGEN BINDING PROTEINS
Next Patent: COMBINATION THERAPY OF AFUCOSYLATED CD20 ANTIBODY WITH FLUDARABINE AND/OR MITOXANTRONE
Next Patent: COMBINATION THERAPY OF AFUCOSYLATED CD20 ANTIBODY WITH FLUDARABINE AND/OR MITOXANTRONE